RxDoctor Payments Data

Carol Bowen-Wells, MD

Surgical Oncology · Jacksonville, FLNPI 1174710982

Payments from drug & device makers

What this record shows

Acell, Inc. accounts for 61.7% of it on its own, with 5 other manufacturers making up the rest.

$3,881in general payments, 2019–2025

Across 11 payments — averaging $352.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acell, Inc.$2K
  • Lumenis BE Inc$1K
  • Medela LLC$139
  • Revance Therapeutics, Inc.$45
  • Mimedx Group, Inc.$31
  • Merz North America, Inc.$22
$51,525in research payments, 2019–2025

Across 1 payment — averaging $51,525 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Acell, Inc.$52K

What the payments were for

  • Speaking & faculty fees$2,13055%
  • Food & beverage$1,75145%

General payments by program year

19
20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,881 in reported general payments places this provider in the 65th percentile of 133 surgical oncology providers in Florida.

See all surgical oncology providers in Florida

Medicare billing

Part B allowed, 2024
$6,053,616
Medicare patients
28
Services billed
5,269

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →